Gregory E Mullen — ASN Events
  1. Schedule
  2. Gregory E Mullen

Greg Mullen

Theragnostics Ltd., BERKSHIRE, United Kingdom

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

First in-man study of 68Ga-THP-PSMA PET in patients with primary prostate cancer: initial results (#32)

3:48 PM
Michael S Hofman
Improving Patient Outcomes with PSMA Theranostics